Cargando…
Vaccines Against Tuberculosis: Problems and Prospects (Review)
Despite the efforts of the global medical and scientific community, tuberculosis remains the leading cause of death from infectious diseases. The expectation of success associated with the development of new anti-TB drugs was not justified, and the attention of researchers was largely drawn to the c...
Autores principales: | Nadolinskaia, N. I., Karpov, D. S., Goncharenko, A. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508421/ https://www.ncbi.nlm.nih.gov/pubmed/32981943 http://dx.doi.org/10.1134/S0003683820050129 |
Ejemplares similares
-
CRISPR Interference of Adenylate Cyclases from Mycobacterium tuberculosis
por: Nadolinskaia, N. I., et al.
Publicado: (2021) -
Fighting Tuberculosis: In Search of a BCG Replacement
por: Nadolinskaia, Nonna I., et al.
Publicado: (2022) -
CRISPR/Cas-Based Approaches to Study Schizophrenia and Other Neurodevelopmental Disorders
por: Kurishev, Artemiy O., et al.
Publicado: (2022) -
Viral Vector Vaccines Against ASF: Problems and Prospectives
por: Ravilov, Rustam Kh., et al.
Publicado: (2022) -
Yeast Rpn4 Links the Proteasome and DNA Repair via RAD52 Regulation
por: Spasskaya, Daria S., et al.
Publicado: (2020)